These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28049862)

  • 1. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.
    Lee HJ; Choi JK; Ryu HS; Choi CH; Kang EH; Park KS; Min YW; Hong KS
    J Neurogastroenterol Motil; 2017 Jan; 23(1):9-19. PubMed ID: 28049862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Washed microbiota transplantation improves symptoms and intestinal barrier function in patients with functional bowel disorders: a propensity-score matching analysis.
    Ye XY; Chen JY; Wu LH; Luo DP; Ye XH; Wu LQ; He XX
    BMC Gastroenterol; 2024 Jan; 24(1):45. PubMed ID: 38262980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in functional bowel disorders.
    Hod K; Ringel Y
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):89-97. PubMed ID: 27048900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.
    Ringel Y
    Gastroenterol Clin North Am; 2017 Mar; 46(1):91-101. PubMed ID: 28164856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of 263 cases of functional bowel disorder.
    Tang YR; Wang P; Yin R; Ge JX; Wang GP; Lin L
    World J Gastroenterol; 2013 Mar; 19(9):1466-71. PubMed ID: 23539637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Chronic Constipation: A Review and Update.
    Ohkusa T; Koido S; Nishikawa Y; Sato N
    Front Med (Lausanne); 2019; 6():19. PubMed ID: 30809523
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
    J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    Ono M; Kato M; Miyamoto S; Tsuda M; Mizushima T; Ono S; Nakagawa M; Mabe K; Nakagawa S; Muto S; Shimizu Y; Kudo M; Katsuki S; Meguro T; Sakamoto N
    J Gastroenterol; 2018 Aug; 53(8):916-923. PubMed ID: 29305648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bowel Disorders.
    Mearin F; Lacy BE; Chang L; Chey WD; Lembo AJ; Simren M; Spiller R
    Gastroenterology; 2016 Feb; ():. PubMed ID: 27144627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal pain localization is associated with non-diarrheic Rome III functional gastrointestinal disorders.
    Bouchoucha M; Fysekidis M; Devroede G; Raynaud JJ; Bejou B; Benamouzig R
    Neurogastroenterol Motil; 2013 Aug; 25(8):686-93. PubMed ID: 23710967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatments and therapeutic targets for IBS and other functional bowel disorders.
    Simrén M; Tack J
    Nat Rev Gastroenterol Hepatol; 2018 Oct; 15(10):589-605. PubMed ID: 29930260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional bowel disorders and functional abdominal pain.
    Thompson WG; Longstreth GF; Drossman DA; Heaton KW; Irvine EJ; Müller-Lissner SA
    Gut; 1999 Sep; 45 Suppl 2(Suppl 2):II43-7. PubMed ID: 10457044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria.
    Long Y; Huang Z; Deng Y; Chu H; Zheng X; Yang J; Zhu Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27412422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
    Cash BD
    Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran.
    Roshandel D; Rezailashkajani M; Shafaee S; Zali MR
    Int J Colorectal Dis; 2006 Dec; 21(8):814-25. PubMed ID: 16565819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional bowel disorders.
    Longstreth GF; Thompson WG; Chey WD; Houghton LA; Mearin F; Spiller RC
    Gastroenterology; 2006 Apr; 130(5):1480-91. PubMed ID: 16678561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.